ARCHIVES

Peter Boyle Elected IARC Director

This article is from The Cancer Letter archive.

Vol. 29 No. 21 | May 23, 2003

Download PDF Visit The Full Archive

Related Articles

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Funding opportunities listed.

March 26, 2004

Abstracts of Papers From ASCO Meeting

April 14, 1978

In Brief: David Kessler Nominated For FDA; Salahuddin Sentenced to Research; B.J. Kennedy Honored

October 26, 1990

NCI To Fund 29% Of Grants In 1990, With Budget Cuts

February 17, 1989

NCA Urges Switching More Funds To Grants From Contract Programs Over Entire Three Years

July 2, 1976